Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Most currently available vaccines target acute infectious agents such as polio, smallpox and influenza virus. The development of vaccines to persistent infectious agents has proven much more difficult. Although it is possible to generate T cell responses to such viruses, these responses are currently unable to prevent the establishment of infection, and immune control may be lost during the chronic phase. Recent advances have increased our understanding of the interactions between persistent viruses and the available T cell repertoire, and will guide approaches to the generation and maintenance of an 'ideal' T cell response.

Original publication

DOI

10.1016/j.coi.2007.04.001

Type

Journal article

Journal

Curr Opin Immunol

Publication Date

06/2007

Volume

19

Pages

294 - 300

Keywords

Animals, Cytotoxicity, Immunologic, Humans, Lymphocyte Activation, T-Lymphocytes, Viral Vaccines, Virus Diseases